Prediction of response to primary chemotherapy for operable breast cancer

By Colleoni M.   Orvieto E.   Nole   Orlando L.   Minchella I.   Viale G.   Peruzzotti G.   Robertson C.   Noberasco C.   Galimberti V.   Sacchini V.   Veronesi P.   Zurrida S.   Orecchia R.   Goldhirsch A.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 574-579

Elsevier

Access to resources Recommend Favorite

Clinical and Pathological Response to Primary Chemotherapy in Operable Breast Cancer

By Chollet P.   Charrier S.   Brain E.   Cure H.   van Praagh I.   Feillel V.   de Latour M.   Dauplat J.   Misset J.-L.   Ferriere J.-P.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 862-866

Elsevier

Access to resources Recommend Favorite

Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer

By Dixon J.M.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel: In the Treatment of Operable Breast Cancer

By Susan J. Keam   Lesley J. Scott  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 325-332

Adis International

Access to resources Recommend Favorite

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite